As global markets navigate a landscape marked by interest rate cuts from the ECB and SNB, and with the Nasdaq reaching new heights despite broader index declines, investors are keenly observing ...
Innoviva Specialty Therapeutics, Inc., ("IST") a subsidiary of Innoviva, Inc. , today announced it has entered into an exclusive distribution and license agreement with Basilea Pharmaceutica Ltd, ...